These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 12357242)

  • 21. Sepsis and endothelial permeability.
    Lee WL; Slutsky AS
    N Engl J Med; 2010 Aug; 363(7):689-91. PubMed ID: 20818861
    [No Abstract]   [Full Text] [Related]  

  • 22. The dynamics of LPS recognition: complex orchestration of multiple receptors.
    Triantafilou M; Triantafilou K
    J Endotoxin Res; 2005; 11(1):5-11. PubMed ID: 15826372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inferences, questions and possibilities in Toll-like receptor signalling.
    Beutler B
    Nature; 2004 Jul; 430(6996):257-63. PubMed ID: 15241424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. From plankton to pathogen recognition.
    Modlin RL; Cheng G
    Nat Med; 2004 Nov; 10(11):1173-4. PubMed ID: 15516915
    [No Abstract]   [Full Text] [Related]  

  • 25. Neisseria meningitidis can induce pro-inflammatory cytokine production via pathways independent from CD14 and toll-like receptor 4.
    Sprong T; van der Ley P; Steeghs L; Taw WJ; Verver-Janssen TJ; Netea MG; van der Meer JW; van Deuren M
    Eur Cytokine Netw; 2002; 13(4):411-7. PubMed ID: 12517725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist.
    Mullarkey M; Rose JR; Bristol J; Kawata T; Kimura A; Kobayashi S; Przetak M; Chow J; Gusovsky F; Christ WJ; Rossignol DP
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1093-102. PubMed ID: 12604686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The CD14 region spanning amino acids 57-64 is critical for interaction with the extracellular Toll-like receptor 2 domain.
    Iwaki D; Nishitani C; Mitsuzawa H; Hyakushima N; Sano H; Kuroki Y
    Biochem Biophys Res Commun; 2005 Mar; 328(1):173-6. PubMed ID: 15670766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toll-like receptor-4 (TLR4) signaling augments chemokine-induced neutrophil migration by modulating cell surface expression of chemokine receptors.
    Fan J; Malik AB
    Nat Med; 2003 Mar; 9(3):315-21. PubMed ID: 12592402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Responsiveness of intestinal epithelial cell lines to lipopolysaccharide is correlated with Toll-like receptor 4 but not Toll-like receptor 2 or CD14 expression.
    Böcker U; Yezerskyy O; Feick P; Manigold T; Panja A; Kalina U; Herweck F; Rossol S; Singer MV
    Int J Colorectal Dis; 2003 Jan; 18(1):25-32. PubMed ID: 12458377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of the lipopolysaccharide receptor complex (CD14, TLR4, MD-2) and toll-like receptor 2 in systemic inflammatory response syndrome-positive patients with and without infection: relationship to tolerance.
    Calvano JE; Agnese DM; Um JY; Goshima M; Singhal R; Coyle SM; Reddell MT; Kumar A; Calvano SE; Lowry SF
    Shock; 2003 Nov; 20(5):415-9. PubMed ID: 14560104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4.
    Yamamoto M; Sato S; Hemmi H; Sanjo H; Uematsu S; Kaisho T; Hoshino K; Takeuchi O; Kobayashi M; Fujita T; Takeda K; Akira S
    Nature; 2002 Nov; 420(6913):324-9. PubMed ID: 12447441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxidized phospholipid inhibition of LPS-signaling: a good side to the bad guys?
    Erridge C
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):337-8. PubMed ID: 19228608
    [No Abstract]   [Full Text] [Related]  

  • 33. Ligand-dependent Toll-like receptor 4 (TLR4)-oligomerization is directly linked with TLR4-signaling.
    Saitoh S; Akashi S; Yamada T; Tanimura N; Matsumoto F; Fukase K; Kusumoto S; Kosugi A; Miyake K
    J Endotoxin Res; 2004; 10(4):257-60. PubMed ID: 15373971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Innate immune recognition of lipopolysaccharide by endothelial cells.
    Henneke P; Golenbock DT
    Crit Care Med; 2002 May; 30(5 Suppl):S207-13. PubMed ID: 12004237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Toll-like trigger for autoimmune disease.
    Bach JF
    Nat Med; 2005 Feb; 11(2):120-1. PubMed ID: 15692591
    [No Abstract]   [Full Text] [Related]  

  • 36. Epithelial cells pay a Toll for protection.
    Strober W
    Nat Med; 2004 Sep; 10(9):898-900. PubMed ID: 15340409
    [No Abstract]   [Full Text] [Related]  

  • 37. Identification of meningococcal LPS as a major monocyte activator in IL-10 depleted shock plasmas and CSF by blocking the CD14-TLR4 receptor complex.
    Bjerre A; Brusletto B; Øvstebø R; Joø GB; Kierulf P; Brandtzaeg P
    J Endotoxin Res; 2003; 9(3):155-63. PubMed ID: 12831456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunology: another toll road.
    Yeh WC; Chen NJ
    Nature; 2003 Aug; 424(6950):736-7. PubMed ID: 12917669
    [No Abstract]   [Full Text] [Related]  

  • 39. [Genetic susceptibility to infections].
    Philippart F; Charpentier J; Mira JP
    Rev Mal Respir; 2002 Sep; 19(4):411-4. PubMed ID: 12417856
    [No Abstract]   [Full Text] [Related]  

  • 40. Lipopolysaccharide and the lung: a story of love and hate.
    Bals R
    Eur Respir J; 2005 May; 25(5):776-7. PubMed ID: 15863630
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.